BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
1.420
+0.100 (7.58%)
At close: Oct 8, 2025, 4:00 PM EDT
1.400
-0.020 (-1.41%)
After-hours: Oct 8, 2025, 6:59 PM EDT
BioCardia Market Cap
BioCardia has a market cap or net worth of $15.06 million as of October 8, 2025. Its market cap has increased by 69.36% in one year.
Market Cap
15.06M
Enterprise Value
14.83M
1-Year Change
69.36%
Ranking
Category
Stock Price
$1.42
Market Cap Chart
Since October 26, 2016, BioCardia's market cap has decreased from $29.07M to $15.06M, a decrease of -48.19%. That is a compound annual growth rate of -7.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 14.00M | 40.12% |
| Dec 31, 2024 | 9.99M | -36.30% |
| Dec 29, 2023 | 15.69M | -62.55% |
| Dec 30, 2022 | 41.90M | 28.00% |
| Dec 31, 2021 | 32.73M | -33.47% |
| Dec 31, 2020 | 49.20M | 95.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |